(Q38309007)

English

Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor

scientific article published on 28 July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

6

object named as

Jerome P Richie

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Nishit K Mukhopadhyay

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Angeline S Ferdinand

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Lipi Mukhopadhyay

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Bekir Cinar

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Mohini Lutchman

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Michael R Freeman

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Brian C-S Liu

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

28 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

312

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

3782-3795

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Androgen receptors in endocrine-therapy-resistant human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Steroid hormone receptors compete for factors that mediate their enhancer function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Androgen receptor in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Control of apoptosis by Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Rel/NF-kappa B/I kappa B signal transduction in the generation and treatment of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Nuclear factor kappa-B and the heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Asthma therapy in the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

SIGNAL TRANSDUCTION:IkB Kinases: Kinsmen with Different Crafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Mutual transcriptional interference between RelA and androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

c-Rel is required for chromatin remodeling across the IL-2 gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Use of chromatin immunoprecipitation to clone novel E2F target promoters

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Analysis of the DNA-binding and activation properties of the human transcription factor AP-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Signaling Cross-talk from Gβ4 Subunit to Elk-1 in the Rapid Action of Androgens

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Regulation of CLOCK and MOP4 by Nuclear Hormone Receptors in the Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.07.017

7 January 2021

Identifiers

10.1016/J.YEXCR.2006.07.017

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38309007&oldid=2173062226"